The prevalence of psychological co-morbidity in people with vitiligo: a systematic review and meta-analysis

Osinubi, O. and Grainge, Matthew J. and Ahmed, A. and Batchelor, Jonathan M. and Grindlay, Douglas and Thompson, A.R. and Ratib, Sonia (2018) The prevalence of psychological co-morbidity in people with vitiligo: a systematic review and meta-analysis. British Journal of Dermatology, 178 (4). pp. 863-878. ISSN 1365-2133

[img] PDF - Repository staff only until 9 October 2018. - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (789kB)

Abstract

Background: Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0.2 to 1.8%. UK guidelines recommend assessment of psychological state during clinical evaluation of vitiligo. However, the prevalence of psychological co-morbidity in people with vitiligo has not been described.

Objectives: We aimed to establish the prevalence of psychological symptoms or disorders in people with vitiligo and describe the outcome measures used.

Methods: We performed a comprehensive search of MEDLINE, Embase, CINAHL and PsychInfo to identify observational studies assessing the prevalence of psychological symptoms or disorders (December 2016). DerSimonian and Lard random-effects models were utilized to estimate the overall pooled prevalence.

Results: We identified 29 studies with 2530 people with vitiligo. Most studies included a measure of either depression (n=25) or anxiety (n=13).The commonest tools were the Hospital Anxiety and Depression Scale and the Centre for Epidemiology Studies Depression Scale. Ten studies provided information on thirteen other psychological outcomes. Pooled prevalence using depression-specific and anxiety-specific questionnaires was 0.29 (95%CI 0.21, 0.38) and 0.33 (95%CI 0.18, 0.49) respectively. Prevalence was lower for clinically diagnosed depression (0.21; 95%CI 0.15, 0.28) and anxiety (0.15; 95%CI 0.06, 0.24). When non-specific tools were used the prevalence remained similar for depression (0.27; 95%CI 0.08, 0.46) but increased for anxiety (0.46; 95% CI 0.39, 0.52). High heterogeneity was observed.

Conclusions: A range of psychological outcomes are common in people with vitiligo. The prevalence of anxiety was influenced by type of screening tool, suggesting validation of psychological outcome screening tools in the field of dermatology.

Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Osinubi, O., Grainge, M.J., Hong, L., Ahmed, A., Batchelor, J.M., Grindlay, D., Thompson, A.R. and Ratib, S. (2018), The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 178:863-878. doi:10.1111/bjd.16049, which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1111/bjd.16049/full. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Schools/Departments: University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine > Division of Epidemiology and Public Health
University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine > Division of Rheumatology, Orthopaedics and Dermatology
Identification Number: https://doi.org/10.1111/bjd.16049
Depositing User: Eprints, Support
Date Deposited: 09 Oct 2017 10:23
Last Modified: 01 May 2018 15:11
URI: http://eprints.nottingham.ac.uk/id/eprint/47088

Actions (Archive Staff Only)

Edit View Edit View